NFKB1 and mastitis: Previous studies have shown that AG can inhibit the expression of lipopolysaccharide-induced inflammatory mediators in macrophages through the NF-κB pathway; AG can reduce mastitis (29), lung injury (30), uterine and epithelial inflammation (31), and colitis (32) in mice or rats by regulating the expression of NF-κB signaling components.